Cystic Fibrosis Trial, Recruiting NCT03670472 Sponsor: University Hospital, Lille Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT03670472
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 8 years or older, both male and female
  • People who have cystic fibrosis caused by a specific type of genetic change called a nonsense mutation, present on both copies of the CFTR gene
  • People whose CFTR gene type has already been identified through genetic testing
  • People who are covered by social security
  • Adults who have given their own written consent to participate
  • Children and teenagers under 18 where a parent or guardian has given permission for them to participate

Who may not be able to join:

  • People whose cystic fibrosis is caused by a type of genetic change other than a nonsense mutation in the CFTR gene
  • People who have not had both copies of their CFTR gene fully tested and identified
  • People who do not wish to participate, or who are unable to give consent and have no one available to give it on their behalf
  • Women who are pregnant or currently breastfeeding
  • People who are under a legal protection order such as curatorship or guardianship (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anne Prévotat, MD, University Hospital, Lille

Phone: 03 20 44 59 48

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 February 2016
Est. completion
1 January 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Transport of iodide ions through the CEVAS membrane

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov